Johnson & Johnson (JNJ) News Today → After Conviction, More Bad News for Trump (From Paradigm Press) (Ad) Free JNJ Stock Alerts $147.08 +0.66 (+0.45%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 8 at 12:17 AM | marketbeat.comWealth Quarterback LLC Has $3.41 Million Stock Holdings in Johnson & Johnson (NYSE:JNJ)Wealth Quarterback LLC raised its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 107.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,746 shares of the compJune 7 at 1:40 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Trading 1.1% Higher Johnson & Johnson (NYSE:JNJ) Stock Price Up 1.1%June 7 at 12:39 PM | investorplace.comThe 3 Best Dow Stocks to Buy in June 2024June 7 at 11:48 AM | reuters.comJ&J-backed Rapport Therapeutics valued at $636.8 mln after shares rise 6% in debutJune 7 at 7:10 AM | investorplace.comThe Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with CashJune 7 at 4:21 AM | fool.com3 Dow Stocks That Are No-Brainer Buys in JuneJune 7 at 12:09 AM | marketbeat.comPinebridge Investments L.P. Acquires 61,214 Shares of Johnson & Johnson (NYSE:JNJ)Pinebridge Investments L.P. lifted its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 13.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 532,218 shares of the company's stock after acquiring aJune 6 at 7:57 PM | reuters.comJ&J-backed Rapport Therapeutics raises $136 mln in US IPOJune 6 at 2:28 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stock Price Up 0.3%Johnson & Johnson (NYSE:JNJ) Trading 0.3% HigherJune 6 at 12:19 PM | marketbeat.comTop Biotech Stocks: Exploring Innovation Opportunities (JNJ)One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccinesJune 6 at 2:34 AM | americanbankingnews.comRoyal Bank of Canada Reiterates "Outperform" Rating for Johnson & Johnson (NYSE:JNJ)June 5 at 2:34 PM | marketbeat.comLake Street Advisors Group LLC Sells 6,506 Shares of Johnson & Johnson (NYSE:JNJ)Lake Street Advisors Group LLC reduced its position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 35.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,024 shares of the company'sJune 5 at 2:20 PM | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stock Price Down 0.7%Johnson & Johnson (NYSE:JNJ) Shares Down 0.7%June 4, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Position Raised by Bell Asset Management LtdBell Asset Management Ltd lifted its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 16.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 105,889 shares of the company's stock after buying anJune 4, 2024 | businesswire.comJohnson & Johnson to Host Investor Conference Call on Second-Quarter ResultsJune 4, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Down 0.4% Johnson & Johnson (NYSE:JNJ) Trading Down 0.4%June 4, 2024 | marketbeat.comRoyal Bank of Canada Reiterates Outperform Rating for Johnson & Johnson (NYSE:JNJ)Royal Bank of Canada reissued an "outperform" rating and issued a $175.00 price objective on shares of Johnson & Johnson in a research report on Tuesday.June 4, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Bought by Edge Capital Group LLCEdge Capital Group LLC raised its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 12.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 111,673 shares of the company's stock after aJune 3, 2024 | businesswire.comOregon Jury Awards $260 Million in Mesothelioma Case Against Johnson & JohnsonJune 3, 2024 | reuters.comJ&J must pay $260 million in latest talc trial, Oregon jury saysJune 3, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stock Price Up 1.1%Johnson & Johnson (NYSE:JNJ) Stock Price Up 1.1%June 3, 2024 | reuters.comJ&J-backed Rapport Therapeutics seeks about $637 mln valuation in US IPOJune 3, 2024 | investorplace.com7 Overlooked Stocks That Belong in Every PortfolioJune 3, 2024 | marketbeat.comRobinson Smith Wealth Advisors LLC Makes New $6.68 Million Investment in Johnson & Johnson (NYSE:JNJ)Robinson Smith Wealth Advisors LLC bought a new position in Johnson & Johnson (NYSE:JNJ - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 42,621 shares of the company's stock, valued at approximately $6,680,000.June 1, 2024 | marketbeat.comAlberta Investment Management Corp Raises Stake in Johnson & Johnson (NYSE:JNJ)Alberta Investment Management Corp increased its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 18.6% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 73,075 shares of the company's stock after buying an additional 11,475 shares during the quarter.June 1, 2024 | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Now Covered by The Goldman Sachs GroupJune 1, 2024 | fool.com3 Magnificent Dividend Stocks to Buy and Hold ForeverJune 1, 2024 | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Receives Consensus Recommendation of "Hold" from BrokeragesMay 31, 2024 | marketbeat.comJ. L. Bainbridge & Co. Inc. Decreases Stock Position in Johnson & Johnson (NYSE:JNJ)J. L. Bainbridge & Co. Inc. trimmed its stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 4.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 157,625 shares of the company's stock afterMay 31, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Stock Price Up 0.9%Johnson & Johnson (NYSE:JNJ) Shares Up 0.9%May 31, 2024 | seekingalpha.comJohnson & Johnson: Market Will Regret The OverreactionMay 31, 2024 | investorplace.comBoring Is Beautiful: 3 Blue-Chip Stocks to Buy and Hold ForeverMay 31, 2024 | businesswire.comJohnson & Johnson Completes Acquisition of Shockwave MedicalMay 30, 2024 | marketbeat.comTFO Wealth Partners LLC Purchases 13,348 Shares of Johnson & Johnson (NYSE:JNJ)TFO Wealth Partners LLC lifted its position in Johnson & Johnson (NYSE:JNJ - Free Report) by 2,557.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,870 shares of the company's stock after acquiring an additional 13,348 shaMay 30, 2024 | cnbc.comHealthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conferenceMay 30, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Trading 0.2% Higher Johnson & Johnson (NYSE:JNJ) Shares Up 0.2%May 30, 2024 | fool.com3 Stocks That Could Be Easy Wealth BuildersMay 30, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Coverage Initiated by Analysts at The Goldman Sachs GroupThe Goldman Sachs Group initiated coverage on Johnson & Johnson in a research note on Thursday. They set a "neutral" rating and a $160.00 target price for the company.May 30, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Acquired by Comgest Global Investors S.A.S.Comgest Global Investors S.A.S. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 0.3% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,816,614 shares of the company's stock after buying an additional 5,585 shares during the quarter.May 29, 2024 | theglobeandmail.comJohnson & Johnson’s experimental drug eases depression, insomnia symptoms in late-stage studyMay 29, 2024 | msn.comJohnson & Johnson's Drug Seltorexant Aces Late-Stage Depression TrialMay 29, 2024 | prnewswire.comSarepta Therapeutics Set to Join S&P MidCap 400May 29, 2024 | seekingalpha.comJohnson & Johnson (JNJ) Bernstein's 40th Annual Strategic Decisions Conference - (Transcript)May 29, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Trading 0.1% Higher Johnson & Johnson (NYSE:JNJ) Trading 0.1% HigherMay 29, 2024 | finance.yahoo.comJohnson & Johnson (NYSE:JNJ) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?May 29, 2024 | reuters.comJ&J's treatment for depression succeeds in late stage studyMay 29, 2024 | americanbankingnews.comJohnson & Johnson (NYSE:JNJ) Trading Down 1.8%May 28, 2024 | marketbeat.comJohnson & Johnson (NYSE:JNJ) Shares Sold by Legacy Advisors LLCLegacy Advisors LLC reduced its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 10.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,202 shares of the company's stock after selliMay 28, 2024 | msn.comM&A News: JNJ Snaps Up Ezcema Drug Maker Yellow Jersey for $1.25BMay 28, 2024 | finance.yahoo.comJohnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (Ad)Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from these levels. But there are at least 10 different coins that I like even better. Related Videos JNJ Media Mentions By Week JNJ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JNJ News Sentiment▼0.710.73▲Average Medical News Sentiment JNJ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JNJ Articles This Week▼2829▲JNJ Articles Average Week Get Johnson & Johnson News Delivered to You Automatically Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eli Lilly and Company News Today Merck & Co., Inc. News Today AbbVie News Today Pfizer News Today Bristol-Myers Squibb News Today Zoetis News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Corcept Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:JNJ) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredNvidia has Apple and Microsoft within striking rangeA small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. W...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Johnson & Johnson Please log in to your account or sign up in order to add this asset to your watchlist. Share Johnson & Johnson With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
